SecBot SecBot
DEFA14A ·Filed Apr 17, 2026

ORKA

Oruka Therapeutics, Inc.
NEUTRAL
Impact 3/10
Horizonimmediate Processed7mo ago SEC0001213900-26-045169
Proxy solicitation materials
Actionable Insight • Neutral

This is a standard, non-contentious annual meeting. Traders should note that the proposals are routine and are expected to pass with strong support, as is typical for management-backed votes. No significant market movement is anticipated from this filing.

DirectionNeutral
Confidencehigh
Horizonimmediate

How the stock moved after the report

NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60
Entry
$68.87
T+0 close · Apr 17, 2026 · via day close
Latest settled
+25.82%
T+60 · $86.65
Vs SPY
+19.04%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Apr 20 $68.87entry
  2. T+1 · 7mo ago +0.19%α +0.84% · $69.00
  3. T+5 · 7mo ago +10.92%α +10.01% · $76.39
  4. T+20 · 6mo ago −15.29%α −19.49% · $58.34
  5. T+60 · 4mo ago +25.82%α +19.04% · $86.65
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Oruka Therapeutics, Inc. (ORKA) has filed a definitive proxy statement (DEFA14A) for its 2026 Annual Meeting, scheduled for June 2, 2026. The meeting will address the election of two Class II directors, the ratification of PricewaterhouseCoopers LLP as the independent auditor, and the advisory approval of executive compensation. This is a routine annual shareholder meeting with no activist involvement or contentious issues.

Key Financial Metrics

Vote
director election
Meeting
2026-06-02
Seats Contested
2

Key Facts

  • The filing is a routine annual proxy statement for the 2026 shareholder meeting.
  • Three proposals are on the agenda: election of two Class II directors (Lawrence Klein and Chris Martin), ratification of the independent auditor, and advisory approval of executive compensation.
  • The meeting will be held virtually on June 2, 2026.
  • The filing was made by the registrant (Oruka Therapeutics, Inc.), indicating it is a standard management proposal.

Financial Impact

No direct financial impact from the filing itself.

Risk Factors

  • None identified from the filing itself.
  • General market risk associated with the company's performance, which is not addressed in this filing.

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations

Investment Themes

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
DEFA14A Filing (Primary)0001213900-26-045169
Document: 0001213900-26-045169-index-headers.html0001213900-26-045169
Document: 0001213900-26-045169-index.html0001213900-26-045169
Document: 0001213900-26-045169.txt0001213900-26-045169

Track record

40 reports on ORKA

Performance horizon

7 of 10 bullish or bearish reports moved the stock their way by T+20. Best: +80.05% at T+60 after the Jun 1, 2026 report. 11 of 11 went positive at some point.

Filters
  1. Nov 16, 2026today SC 13G Neutral 3/10 Entry $102.46 Now $99.24 −3.14% settles Dec 15
  2. Nov 16, 2026today SC 13G/A Neutral 2/10 Entry $104.40 Now $99.24 −4.94% settles Dec 15
  3. Nov 13, 20263d ago Insider Cluster Neutral 2/10 Entry $106.15 Now $99.24 −6.51% settles Dec 15
  4. Nov 13, 20263d ago Insider Cluster Neutral 2/10 Entry $104.89 Now $99.24 −5.39% settles Dec 15
  5. Nov 12, 20264d ago 144 Neutral 2/10 Entry $105.35 Now $99.24 −5.80% settles Dec 14
  6. Nov 12, 20264d ago 144 Neutral 2/10 Entry $105.35 Now $99.24 −5.80% settles Dec 14
  7. Nov 9, 20267d ago Press Release Neutral 5/10 Entry $109.50 Now $99.24 −9.37% settles Dec 9
  8. Nov 2, 202614d ago Institutional Cluster Neutral 2/10 Entry $99.55 Now $99.24 −0.31% settles Dec 2
  9. Nov 2, 202614d ago 144 Neutral 3/10 Entry $99.55 Now $99.24 −0.31% settles Dec 2
  10. Oct 26, 202621d ago 8-K Bullish 6/10 Entry $90.33 Now $99.24 +9.86% settles Nov 23
Showing 10 of 40

US Market Status

Market Closed · Opens in 8h 32m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Apr 17, 2026